Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers
The market for clinical trials in China is currently experiencing significant growth, driven by increasing activity from both Chinese sponsors…
The market for clinical trials in China is currently experiencing significant growth, driven by increasing activity from both Chinese sponsors…
In 2021, the Project Optimus initiative was launched by the US Food and Drug Administration’s (FDA) Oncology Center of Excellence,…
By taking a more strategic approach to PASS, you can secure long-term market access, gain regulatory trust, and provide critical…
The European orphan drug market is growing and is already comparable in size and scope to the US market. The…
Estimates suggest that there could be around 300 million people worldwide living with a rare disease. A disease is classed as…
Antibody drug conjugates (ADCs) represent a promising new generation of cancer therapeutics and a significant advance in targeted drug delivery.…
Meticulous planning is central to building an effective clinical trial, powered by well-designed Interactive Response Technology (IRT) which provides not…
Used in consumer products since the 1950s, perfluoroalkyl and polyfluoroalkyl substances (PFAS) are synthetic chemicals with strong fluorine-carbon bonds, earning…
Medication non-adherence is an enduring issue in the UK healthcare system, costing the NHS a staggering £930 million annually.[i] Despite…
Despite inflationary pressures and ongoing challenges in the geopolitical landscape, expectations are high regarding the biopharmaceutical industry’s growth prospects. A…